Does EVOLOCUMAB Cause Coronary artery bypass? 147 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Coronary artery bypass have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.
147
Reports of Coronary artery bypass with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
4
Deaths
54
Hospitalizations
How Dangerous Is Coronary artery bypass From EVOLOCUMAB?
Of the 147 reports, 4 (2.7%) resulted in death, 54 (36.7%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Coronary artery bypass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 147 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Coronary artery bypass?
ROSIGLITAZONE (1,181)
METFORMIN\ROSIGLITAZONE (181)
ADALIMUMAB (162)
AVANDIA (111)
RANOLAZINE (100)
RISANKIZUMAB-RZAA (93)
ETANERCEPT (76)
FLUTICASONE\SALMETEROL (75)
ASPIRIN (64)
INSULIN GLARGINE (62)
Which EVOLOCUMAB Alternatives Have Lower Coronary artery bypass Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE